Picture of LifeSafe Holdings logo

LIFS LifeSafe Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapNeutral

REG - LifeSafe Holdings - Final Results

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230418:nRSR5010Wa&default-theme=true

RNS Number : 5010W  LifeSafe Holdings PLC  18 April 2023

 For immediate release  18 April 2023

 

LifeSafe Holdings plc

('LifeSafe', the 'Group' or the 'Company')

 

Final Results for the year ended 31 December 2022

 

Excellent operational and strategic performance

 

LifeSafe (AIM:LIFS), a fire safety technology business with innovative fire
extinguishing fluids and fire safety products, reports its maiden audited
Final Results for the year ended 31 December 2022 ('FY22' or 'the Period').

 

Financial highlights:

 

 ·           Successful IPO and Admission to AIM on 6 July 2022 raising gross proceeds of
             £3.0 million
 ·           Revenue up significantly to £4.0 million (2021: £670,000), exceeding
             previous market expectations
 ·           Gross profit of £2.3 million at 57.0% margin (2021: £312,000 at 46.6%
             margin)
 ·           Underlying loss before interest, tax, depreciation and amortisation(1)
             ('underlying LBITDA') of £1.3 million (2021: underlying LBITDA of £1.3
             million)
 ·           Underlying loss from operations(2) of £1.4 million (2021: loss of £1.4
             million); loss from operations of £2.8 million (2021: loss of £1.5 million)
 ·           Non-underlying costs of £1.6 million (2021: £162,000) comprising IPO costs
             charged to the income statement of £727,000, share-based payment charges of
             £630,000, other non-underlying costs of £58,000 and convertible loan
             interest on loans converted to equity on Admission to AIM of £187,000
 ·           Underlying loss before tax(3) of £1.4 million (2021: loss of £1.4 million);
             loss before tax of £3.0 million (2021: loss of £1.5 million)
 ·           Capitalised product development spend of £0.4 million (2021: £0.1 million)
 ·           Cash and cash equivalents at 31 December 2022 of £1.2 million (31 December
             2021: £64,000)
 ·           Net cash at 31 December 2022 of £1.1 million (31 December 2021: net debt of
             £0.5 million)

 

Operational highlights

 

 ·           Launched the StaySafe 5-in-1 in the US on Amazon and Lifesafetechnologies.com
             in February 2022, building on the position of Amazon Prime's top selling fire
             extinguisher in the UK
 ·           UK patent granted for the Group's FER1000 eco-friendly fire extinguishing
             fluid
 ·           UK and international patent applications submitted for the Company's new
             fluid, the LifeSafe Lithium Thermal Runaway Fluid, the effectiveness of which
             has been demonstrated through a series of live fire tests to a number of
             industry leaders to help and support the commercialisation of the fluid into
             the industrial market sector
 ·           Launch of new website www.lifesafeindustrial.com
             (http://www.lifesafeindustrial.com) to focus on the applications and uses of
             the Group's new and future fluid developments for customers in the industrial
             sector

 ·           Strong pipeline of innovative new products and fluid derivatives expected to
             launch in H1 2023

 ·           Solid start to 2023 with sales ahead of budget and over four times those of
             the first two months of 2022 and gross margin ahead of last year by almost 4%

(1) Underlying LBITDA represents loss for the year before finance expense,
tax, depreciation and amortisation, and non-underlying items (which comprise
IPO listing costs, share-based payment charges and other non-underlying
items).

( )

(2) Underlying loss from operations represents loss for the year before
finance expense, tax and non-underlying items (which comprise IPO listing
costs, share-based payment charges and other non-underlying items).

( )

(3) Underlying loss before tax represents loss for the year before tax and
non-underlying items (which comprise IPO listing costs, share-based payment
charges, other non-underlying items and convertible loan note interest).

 

Commenting on the maiden Final Results, Dominic Berger, Executive Chairman of
LifeSafe, said: "I am extremely pleased to report the excellent operational
and strategic progress made by the Group in FY22.  In addition to the Group's
successful IPO and admission to AIM in July 2022, one of only a handful of
successful AIM listings in the year, significant progress has been made in
commercialising LifeSafe's core product after a number of years of innovation,
development and refinement of the Group's proprietary fire extinguishing
fluid.

 

"Revenue materially exceeded the Board's expectations set both at the
beginning of 2022 and reset towards the end of the year.  This was a
phenomenal achievement against a worsening domestic and international
macro-economic landscape as the year progressed, and even more impressive
considering that LifeSafe only commenced trading through Amazon Prime in the
UK in August 2021 and through Amazon US, and our LifeSafe US website, in
February 2022.

 

"We have made a solid start to 2023, outperforming the Group's budget with
sales over four times those of the first two months of 2022 and gross margin
ahead of last year by almost 4%.  We remain on course to reach profitability,
on a monthly basis, in the last few months of 2023."

 

Investor presentation

 

An 'in-person' meeting for sell-side analysts will be held at 9.30am (BST)
today at the offices of Buchanan, 3(rd) Floor, 107 Cheapside, London EC2V
6DN.  Please contact Buchanan via lifeSafe@buchanan.uk.com
(mailto:lifeSafe@buchanan.uk.com) if you wish to join the meeting.

 

The Company will also be hosting a presentation for retail investors to
discuss the announcement on 19 April 2023 at 5.00pm (BST).  Please email
lifesafe@buchanan.uk.com (mailto:lifesafe@buchanan.uk.com) to register your
interest.

 

This announcement contains inside information for the purposes of Article 7 of
the UK version of Regulation (EU) No 596/2014 which is part of UK law by
virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR").  Upon
the publication of this announcement via a Regulatory Information Service,
this inside information is now considered to be in the public domain.

 

The person responsible for arranging the release of this announcement on
behalf of the Company is Mike Stilwell, Chief Financial Officer of the
Company.

 

For further enquiries:

 

 LifeSafe Holdings plc                                Via Buchanan
 Dominic Berger, Chairman                             www.lifesafeholdingsplc.com (http://www.lifesafeholdingsplc.com)
 Neil Smith, CEO
 Mike Stilwell, CFO

 WH Ireland Limited (Nominated Adviser & Broker)      Tel: +44 (0) 20 7220 1666
 Chris Fielding
 Darshan Patel

 Buchanan (Financial Communications)                  Tel: +44 (0) 20 7466 5000
 Henry Harrison-Topham                                LifeSafe@buchanan.uk.com (mailto:LifeSafe@buchanan.uk.com)
 Jack Devoy

 

Notes to Editors

 

LifeSafe is a fire safety technology business that develops eco-friendly,
novel and innovative fire extinguishing fluids with a range of life-saving
fire safety products.  Through its highly experienced management team,
LifeSafe is seeking to create new markets for the Group in fire safety through
new technologies, digital marketing and multi-channel sales.

 

LifeSafe has developed what the Directors believe to be a market disrupting
range of eco-friendly fire safety protection products including, launched in
December 2022, a new Thermal Runaway Fluid to combat thermal runaway in
lithium battery fires by permanently extinguishing and preventing the
re-ignition of lithium fires.  This is an evolution of the Group's core
FER1000 extinguishing fluid, for which the Group has been granted a patent in
the UK, which has been developed by LifeSafe to extinguish five different
types of fire: electrical, paper, textiles, cooking oil, and petrol and
diesel.

 

The Group's best-selling product using this extinguishing fluid is the
StaySafe 5-in-1 fire extinguisher.  It was launched on Amazon Prime in the UK
in August 2021 and subsequently became Amazon Prime's top-selling fire
extinguisher in the UK in the same month.  The StaySafe 5-in-1 and the
PanSafe pan fire extinguisher were launched in Screwfix in Spring 2022.

 

LifeSafe is continuing to develop new fluid derivations for the industrial
market.

 

LifeSafe was admitted to trading on AIM in July 2022 with the ticker LIFS.L.
For additional information please visit https://www.lifesafeholdingsplc.com
(https://www.lifesafeholdingsplc.com) .

 

LinkedIn: https://www.linkedin.com/company/lifesafe-technologies
(https://www.linkedin.com/company/lifesafe-technologies)

Twitter: https://twitter.com/LifesafeT (https://twitter.com/LifesafeT)

 

 

 

Chairman's Statement

 

Overview

I am extremely pleased to report the excellent operational and strategic
progress made by the Group in FY22.  In addition to the Group's successful
IPO and admission to AIM in July 2022, one of only a handful of successful AIM
admissions in the year, significant progress has been made in commercialising
LifeSafe's core product after a number of years of innovation, development and
refinement of the Group's proprietary fire extinguishing fluid.

 

I think it is important to remind shareholders and prospective investors of
the genesis of the business. LifeSafe was formed to explore a novel, and
environmentally friendly approach to putting out multiple types of fire with
an aim to revolutionise the fire industry, save lives and protect memories.
The result was the development of a patented super coolant fire extinguishing
fluid that remains at the core of our business which is non-toxic,
environmentally friendly and extremely effective at putting out multiple fire
types.

 

Once we had developed, tested and secured approvals of our fluids, our
commercial strategy was led by our research where consumers told us they found
purchasing a fire extinguisher difficult and confusing, which is why currently
only 17% of homes in England have a fire extinguisher.  This determined our
market approach.  We therefore decided to launch with our unique StaySafe
5-in-1 fire extinguisher, a handheld plastic aerosol with a digital first,
direct to consumer marketing approach leveraging the likes of the Amazon
platform and harnessing the power of social media to drive awareness and
sales.

 

Today in the UK, our StaySafe 5-in-1 is the number one best-selling fire
extinguisher on Amazon UK.

 

Revenue for FY22, at over £4.0 million, materially exceeded the Board's
expectations set both at the beginning of 2022 and reset towards the end of
the year.  This was a phenomenal achievement against a worsening domestic and
international macro-economic landscape as the year progressed, and even more
impressive considering that LifeSafe only commenced trading through Amazon
Prime in the UK in August 2021 and through Amazon US, and our LifeSafe US
website, in February 2022.

 

In addition to driving sales of our proprietary fire extinguishing fluid to
consumers through digital channels, LifeSafe's team recognises the huge
potential of fluid innovation for industrial and wholesale applications.  In
conjunction with industrial partners, we successfully developed and launched
LifeSafe's Lithium Thermal Runaway Fluid ('TRF') in December 2022,
specifically designed to address the escalating issue of thermal runaway in
lithium batteries by permanently extinguishing and preventing the re-ignition
of lithium fires.

 

The Group is on track in executing its strategy to build a multi-channel,
international business capable of delivering significant long-term value for
our shareholders.

 

Results

For the year to 31 December 2022, the Group's revenue increased significantly
to £4.0 million (2021: £0.7 million) as the Group successfully began the
commercialisation of its market-disrupting, eco-friendly fire extinguishing
fluid.

 

Gross profit increased significantly to £2.3 million (2021: £0.3 million)
and the gross margin improved to 57.0% (2021: 46.6%) ahead of the Board's
expectations.

 

The Group made an underlying loss before tax(1) of £1.4 million (2021: loss
of £1.4 million).  After charging £1.6 million for non-underlying costs in
relation to the IPO, share-based payment charges and convertible loan note
interest (2021: £162,000 in relation to share-based payment charges and
convertible loan note interest), the consolidated loss before tax for the year
was £3.0 million (2021: loss of £1.5 million).  Underlying LBITDA(2) was
£1.3 million (2021: underlying LBITDA of £1.3 million).

 

 

(1) Underlying loss before tax of £1.4 million is before non-underlying items
of £1.6 million (further details of which are set out in the notes to this
announcement) (2021: underlying loss before tax of £1.4 million before
non-underlying items of £0.2 million).

 

(2) Underlying LBITDA of £1.3 million is loss before tax, before finance
expense of £0.2 million, depreciation and amortisation of £0.1 million, and
non-underlying items of £1.4 million (2021: underlying LBITDA of £1.3
million is loss before tax, before finance expense of £0.1 million,
depreciation and amortisation of £0.1 million, and non-underlying items of
£0.1 million).

 

LifeSafe's underlying results, after separating out the significant costs of
listing and non-core share-based payment charges, are very encouraging and
illustrate a growth trajectory in line with that envisaged on IPO of the Group
during the year.

 

Net cash at 31 December 2022 was £1.1 million (31 December 2021: net debt of
£0.5 million).  All outstanding convertible loan notes converted to equity
on IPO, leaving the Group with debt of only £26,000 at the year end in
relation to a Coronavirus bounce back loan secured during the pandemic.

 

Board appointments

During the year a number of appointments were made to the Board to ensure it
has a structure and composition appropriate for a growing publicly-quoted
business in the fire technology sector.  The Board interactions and
contributions during the year have proved to be extremely valuable and
validate the appointments made and the appropriateness of the mix of skills of
the Board.

 

People

The delivery of an IPO, continual innovation of products and the extraordinary
sales growth during the year could not have been achieved without the
exceptional commitment and resilience of our people and I would like to take
this opportunity to thank them sincerely for their hard work and commitment.

 

Research and development

As I have previously reported, given the strong interest from major industry
players in the potential applications of LifeSafe's fluids, the Group
accelerated its development programme over the year.  This resulted in the
launch of LifeSafe's Lithium TRF in December 2022, the first fully developed
and tested fire extinguishing fluid aimed at the industrial sector to be
released under the Group's programme of innovation.  A variant of the Group's
core eco-friendly patented fluid, this new non-toxic and non-hazardous fluid
has been designed and specified with industry leaders to permanently
extinguish and prevent the re-ignition of lithium battery fires.  The Group
has submitted UK and international patent applications to protect its
innovation.

 

In order to support this significant opportunity in the industrial sector, the
Group developed a new website (www.lifesafeindustrial.com
(http://www.lifesafeindustrial.com) ) specifically focussed on the industrial
applications for the new fluid.  This is distinct and separate from
LifeSafe's consumer website (www.lifesafetechnologies.co.uk), which is
focussed on household consumer applications of the Group's best-selling
StaySafe 5-in-1 fire extinguisher.

 

The Group expects to release further new products from its development
programme in the first half of 2023 and will make announcements as and when
appropriate.

 

Technology and intellectual property

LifeSafe was granted a patent for its core FER1000 extinguishing fluid with
effect from August 2022.  This fluid, for which the initial patent
application was filed in 2017, is at the centre of the Group's product range,
and the base from which specific application variants can be developed.  The
length of time between initial application and patent grant is an indication
of the robust process undertaken to ensure the uniqueness of the Group's
innovation.

 

The Board recognises the importance of protecting its intellectual property
and rigorously guards its innovation.  The Group employs an intellectual
property attorney to protect its interests and has intellectual property
defence and pursuit insurance to protect its investments.

 

 

Outlook

The Group's significant outperformance against the Board's initial revenue
expectations for the year is a clear validation of the quality of LifeSafe's
product and strength of its management team and marketing strategy.

 

The opportunity for our product in the consumer market is significant and we
continue to believe the mantra that every home should have one.  Our laser
focus therefore in the current year is to continue to grow consumer market
penetration across all territories using our tried and tested digital
marketing strategies.

 

We have made a solid start to 2023, outperforming the Group's budget with
sales over four times those of the first two months of 2022 and gross margin
ahead of last year by almost 4%.  The Group remains on course to reach
profitability, on a monthly basis, in the last few months of 2023.

 

The launch of our Lithium TRF represents an important and exciting step for
the Group by expanding our offering into wholesale and industrial markets.
These new market opportunities, combined with the excellent growth in sales of
our consumer-focussed products, positions the Group extremely well to deliver
value for our shareholders.  I am very excited by what lies ahead for
LifeSafe.

 

 

Dominic Berger

Executive Chairman

18 April 2023

 

 

Consolidated statement of comprehensive income

For the year ended 31 December 2022

 

                                                                            2022                                                                  2021

                                                                                                                                                  (Unaudited)
                                        Note                                Non-underlying items (note 6)                                         Non-underlying items (note 6)

                                              Before non-underlying items   £000                                    Before non-underlying items   £000

                                              £000                                                                  £000

                                                                                                           Total                                                                 Total

                                                                                                           £000                                                                  £000
 Revenue                                3     4,028                         -                              4,028    670                           -                              670
 Cost of sales                                (1,732)                       -                              (1,732)  (358)                         -                              (358)
 Gross profit                                 2,296                         -                              2,296    312                           -                              312
 Other operating income                       -                             -                              -        46                            -                              46
 Administrative expenses                4     (3,676)                       (1,415)                        (5,091)  (1,754)                       (114)                          (1,868)
 Loss from operations                         (1,380)                       (1,415)                        (2,795)  (1,396)                       (114)                          (1,510)
 Finance expense                        4,5   (5)                           (187)                          (192)    (1)                           (48)                           (49)
 Other gains                                  -                             -                              -        14                            -                              14
 Loss before tax                              (1,385)                       (1,602)                        (2,987)  (1,383)                       (162)                          (1,545)
 Taxation                               6     173                           -                              173      24                            -                              24
 Loss for the year                            (1,212)                       (1,602)                        (2,814)  (1,359)                       (162)                          (1,521)
 Other comprehensive income
 Total other comprehensive income             -                             -                              -        -                             -                              -
 Total comprehensive expense                  (1,212)                       (1,602)                        (2,814)  (1,359)                       (162)                          (1,521)
 Basic and diluted loss per share (£)   7                                                                  (0.15)                                                                (0.10)

 

All amounts relate to continuing activities.

Consolidated statement of financial position

As at 31 December 2022

 

                                                      Note  As at         As at

31 December
31 December

                                                            2022          2021

                                                            £000          (Unaudited)

£000
 Non-current assets
 Intangible assets                                          483           165
 Property, plant and equipment                              10            11
                                                            493           176
 Current assets
 Inventories                                                442           190
 Trade and other receivables                          8     659           132
 Cash and cash equivalents                            9     1,166         64
                                                            2,267         386
 Total assets                                               2,760         562
 Current liabilities
 Trade and other payables                             10    (1,002)       (262)
 Convertible loan notes                               11    -             (562)
 Borrowings                                           12    (7)           (7)
 Other provisions                                           (24)          (31)
                                                            (1,033)       (862)
 Non-current liabilities
 Borrowings                                           12    (19)          (26)
                                                            (19)          (26)
 Total liabilities                                          (1,052)       (888)
 Net assets/(liabilities)                                   1,708         (326)
 Equity attributable to equity holders of the Parent
 Called up share capital                              13    221           3
 Share premium account                                13    4,152         4,627
 Share-based payment reserve                                857           114
 Convertible loan note reserve                              -             171
 Retained earnings                                          (3,522)       (5,241)
 Total equity                                               1,708         (326)

 

Consolidated statement of changes in equity

For the year ended 31 December 2022

 

 

                                                              Share-based payment

                                                    Share     reserve              Convertible loan note reserve £000

                                          Share     premium   £000                                                       Retained

                                          capital   account                                                              earnings   Total equity

                                          £000      £000                                                                 £000       £000
 Balance at 1 January 2021 (Unaudited)    2         3,347     -                    -                                     (3,720)    (371)
 Comprehensive income
 Loss for the year                        -         -         -                    -                                     (1,521)    (1,521)
 Share-based payments                     -         -         114                  -                                     -          114
 Transactions with owners:
 Shares issued for cash                   -         436       -                    -                                     -          436
 Shares issued in lieu of expenses        1         656       -                    -                                     -          657
 Convertible loan notes exercised         -         188       -                    -                                     -          188
 Convertible loan notes issued            -         -         -                    171                                   -          171
 Balance at 31 December 2021 (Unaudited)  3         4,627     114                  171                                   (5,241)    (326)

 

 

 Balance at 1 January 2022         3    4,627    114  171    (5,241)  (326)
 Comprehensive income
 Loss for the period               -    -        -    -      (2,814)  (2,814)
 Share-based payments              -    -        630  -      -        630
 Issue of warrants                 -    (113)    113  -      -        -
 Transactions with owners:
 Bonus issue of shares             151  -        -    -      (151)    -
 Cancellation of share premium     -    (4,464)  -    -      4,464    -
 Shares issued for cash            40   3,047    -    -      -        3,087
 Share issue costs                 -    (368)    -    -      -        (368)
 Convertible loan notes exercised  27   1,423    -    (354)  220      1,316
 Convertible loan notes issued     -    -        -    183    -        183
 Balance at 31 December 2022       221  4,152    857  -      (3,522)  1,708

 

 

Consolidated statement of cash flows

For the year ended 31 December 2022

 

                                                                  Year ended         Year ended

31 December 2022
31 December 2021 (Unaudited)

                         £000
                                                           Note

      £000

 Cash flows from operating activities
 Loss before taxation from continuing activities                  (2,987)            (1,545)
 Adjustments for non-cash/non-operating items:
 Depreciation of property, plant and equipment                    2                  2
 Amortisation of intangible assets                                90                 52
 Equity-settled expenses                                          -                  657

                                                                                     )
 Gain on debt extinguishment                                      -                  (14)
 IPO costs                                                 4      727                -
 Equity-settled share-based payments                       4      630                114
 Finance expense                                           5      192                49
 Operating cash flows before movements in working capital         (1,346)            (685)
 Increase in inventories                                          (252)              (190)
 Increase in trade and other receivables                   8      (357)              (18)
 Increase/(decrease) in trade and other payables           10     734                (273)
 Cash used in operations                                          (1,221)            (1,166)
 Corporation tax received                                         -                  24
 Net cash used in operating activities                            (1,221)            (1,142)
 Cash flows used in investing activities
 Purchase of property, plant and equipment                        (1)                (10)
 Purchase of intangibles                                          (408)              (123)
 Net cash used in investing activities                            (409)              (133)
 Cash flows from financing activities
 Shares issued for cash (net of expenses)                  13     1,993              436
 Repayment of borrowings                                          (7)                (5)
 Proceeds from issue of convertible loan notes             11     750                833
 Other interest paid                                              (4)                -
 Net cash generated by financing activities                       2,732              1,264
 Net increase/(decrease) in cash and cash equivalents             1,102              (11)
 Cash and cash equivalents at the beginning of the year           64                 75

                                                                                     75
 Cash and cash equivalents at the end of the year          9      1,166              64

 

 

Notes

 

1.    General information

 

These consolidated financial statements were approved by the Board of
Directors on 17 April 2023.

 

2.    Basis of preparation

 

The auditors have issued an unqualified opinion on the full financial
statements for the year ended 31 December 2022 which will be made available
for shareholders and delivered to the Registrar of Companies in due course.
The financial information in this announcement for the years ended 31 December
2022 and 2021 does not constitute statutory financial statements within the
meaning of Section 434 of the Companies Act 2006.  The information contained
within this announcement for the year ended 31 December 2022 has been
extracted from the audited financial statements which have been prepared in
accordance with International Financial Reporting Standards ('IFRS') as
endorsed by the United Kingdom ('adopted IFRS'), and those parts of the
Companies Act 2006 applicable to companies reporting under IFRS.  They have
been prepared using the historical cost convention except where the
measurement of balances at fair value is required.  The financial information
for the year ended 31 December 2021 was not subject to audit and audited group
financial statements were not prepared.  The information in this preliminary
statement has been extracted from the audited financial statements for the
year ended 31 December 2022 and, as such, does not contain all the information
required to be disclosed in the financial statements prepared in accordance
with IFRS.

 

3.    Revenue from contract customers

 

No one customer made up more than 10% or more of revenue in the year ending 31
December 2022 (2021: 1). Management considers revenue derives from one
business stream being the sale of fire extinguishing and related products.

 

 Revenue from customers  Year ended    Year ended

                         31 December   31 December

                         2022          2021

                                       (Unaudited)

                         £000          £000
 Customer 1              -             85
 All other customers     4,028         585
                         4,028         670

 

 

 Geographical reporting  Year ended    Year ended

                         31 December   31 December

                         2022          2021

                                       (Unaudited)

                         £000          £000
 United Kingdom          1,451         585
 North America           2,372         -
 Europe                  180           -
 Rest of the World       25            85
                         4,028         670

 

 

4.    Non-underlying items

                                 Year ended    Year ended

                                 31 December   31 December

                                 2022          2021

                                               (Unaudited)

                                 £000          £000
 IPO costs                       727           -
 Share-based payment charges     630           114
 Other non-underlying costs      58            -
 Within administrative expenses  1,415         114
 Convertible loan note interest  187           48
 Within finance expense          187           48
                                 1,602         162

 

IPO costs

On Admission to AIM on 6 July 2022, the Company issued 4,000,000 new ordinary
shares and 2,716,550 ordinary shares to the providers of convertible loans,
taking the number of ordinary shares in issue to 22,108,050.  The total gross
proceeds amounted to £3,000,000.  The costs of issue amounted to £1,095,000
of which £727,000 was recognised as a non-underlying expense in the
consolidated statement of comprehensive income and £368,000 was allocated to
the share premium account in the consolidated statement of financial position.

 

Share-based payment charges

The total charge recognised for the year in relation to share-based payments
amounted to £630,000 (2021: £114,000).

 

The Group operates equity-settled share-based remuneration schemes for
employees.  The terms and conditions of the grants are detailed below:

                       No. of                                                          Contractual life

 Date of grant         Options    Exercise price (£)    Vesting conditions             of options
 30 September 2021(1)  1,495,650  0.48                  IPO                            10 years
 11 October 2021(1)    1,645,200  0.48                  IPO/market capitalisation      10 years
 29 March 2022(1)      1,645,200  0.16                  12 months from admission date  10 years
 26 July 2022          1,167,301  0.75                  Total shareholder return       10 years
 13 October 2022       974,965    0.75                  Total shareholder return       10 years

(1) The number of share options granted, and the corresponding exercise price,
are shown after the Company's 49 for 1 bonus issue of shares on 9 May 2022.

 

Details of the number of share options granted, exercised, lapsed and
outstanding at the end of each year, as well as the weighted average exercise
prices in £ ('WAEP'), are as follows:

 

                                       As at 31            As at 31

                                       December            December

                                       2022         WAEP   2021          WAEP

                                                    £      (Unaudited)   £

                                       Number              Number
 Outstanding at beginning of the year  3,140,850    0.48   -             -
 Granted during the year               3,787,466    0.49   3,140,850     0.48
 Forfeited/lapsed during the year      (1,645,200)  0.16   -             -
 Exercised during the year             -            -      -             -
 Outstanding at end of the year        5,283,116    0.49   3,140,850     0.48
 Exercisable at end of the year        1,495,650    0.48   -             -

 

5.    Finance expense

 

                                     Year ended    Year ended

                                     31 December   31 December

                                     2022          2021

                                                   (Unaudited)

                                     £000          £000
 Interest on bank loans              5             1
 Interest on convertible loan notes  187           48
                                     192           49

6.    Taxation

 

A tax credit of £173,000 (2021: £24,000) has been recognised in relation to
research and development tax credits available from HMRC through the SME
R&D relief scheme.

 

7.    Loss per share

 

Loss per share is calculated as follows:

 

                                                                         Year ended    Year ended

                                                                         31 December   31 December

                                                                         2022          2021

                                                                                       (Unaudited)
 Basic and diluted loss per share (£)                                    (0.15)        (0.10)
 The  calculations of basic and diluted loss per share are based upon:
 Loss for the year attributable to owners of the Parent (£000)           (2,814)       (1,521)

 Weighted average number of ordinary shares (number)                     18,666,870    15,369,510

 

The calculation of the basic loss per share is based on the results
attributable to ordinary shareholders divided by the weighted average number
of shares in issue during the year.

The weighted average number of shares in issue is used as the denominator in
the calculating basic loss per share.  As the Group is loss making the effect
of instruments that convert into ordinary shares is considered anti-dilutive,
hence there is no difference between the diluted and non-diluted loss per
share.

During the year ended 31 December 2022, the Company completed a 49 for 1 bonus
share issue. As a result, the weighted average number of shares in the
comparative year has been adjusted accordingly.

 

8.    Trade and other receivables

 

                                       31 December 2022  31 December 2021

                                                         (Unaudited)

                                       £000              £000
 Amounts falling due within one year:
 Trade receivables                     17                -
 Other receivables                     160               1
 Taxation and social security          326               107
 Prepayments and accrued income        156               24
                                       659               132

 

9.    Cash and cash equivalents

                                   31 December  31 December

                                   2022         2021

                                                (Unaudited)

                                   £000         £000
 Cash at bank available on demand  1,166        64
                                   1,166        64

 

10.  Trade and other payables

                                       31 December  31 December

                                       2022         2021

                                                    (Unaudited)

                                       £000         £000
 Amounts falling due within one year:
 Trade payables                        665          219
 Other payables                        61           17
 Accruals                              181          -
 Other taxation and social security    95           26
                                       1,002        262

 

11.  Convertible loan notes

 

                                       31 December 2022  31 December 2021

                                                         (Unaudited)

                                       £000              £000
 Amounts falling due within one year:
 Convertible loan notes                -                 562
                                       -                 562

 

In the year ended 31 December 2021, the Group issued loan notes amounting to:

 

- £133,165 with an interest rate of 10% and converting at a 20% discount in
the event of a qualifying fundraise.  The loan notes were unsecured and
repayable on 1 August 2022 or could be converted at any time into shares at
the holder's option.  The presence of potential settlement at a discount to
an unknown fundraise price meant that the fixed for fixed criterion was not
met.  The loans were converted to equity on 4 March 2021 and 21 July 2021 for
£19.25 per ordinary share of 1p, resulting in shares of 2,337 and 4,156 being
issued respectively.

- £700,000 with an interest rate of 12%, with interest accruing to the value
of the loan and converting to equity with the principal in the event of a
conversion.  The loans were unsecured and repayable in two years or could be
converted at any time into shares at the holder's option.  In addition to
interest, there was an arrangement fee and a monitoring fee of 13% and 3% of
principal respectively that was added to the loan balance on drawdown.  The
loan terms included an accelerated interest conversion feature that required a
full year of interest to be converted into equity if the loan was converted
part way through a year.  These loans were converted on 6 July 2022 at
£34.16 per 1p ordinary share.

 

In the year to 31 December 2022, the Company issued loan notes amounting to
£750,000 with an interest rate of 12%, with interest accruing to the value of
the loan and converting to equity with the principal in the event of a
conversion.  The loans were unsecured and repayable in two years or could be
converted at any time into shares at the holder's option.  In addition to
interest, there was an arrangement fee and a monitoring fee of 13% and 3% of
principal respectively that was added to the loan balance on drawdown.  The
loan terms included an accelerated interest conversion feature that required a
full year of interest to be converted into equity if the loans were converted
part way through a year.  These loans were converted on 6 July 2022 at
£34.16 per 1p ordinary share.

 

As the conversion feature resulted in the conversion of a fixed amount of
stated principal into a fixed number of shares, it satisfied the 'fixed for
fixed' criterion and, therefore, it is classified as an equity instrument.
The value of the liability component and the equity conversion component were
determined at the date the instrument was issued.  The fair value of the
liability component at inception was calculated using a market interest rate
for an equivalent instrument without conversion option.  The discount rate
applied was 15%.  The transaction costs have been apportioned between the
equity and liability component with the portion attributable to equity
recognised as a deduction in equity, and the liability component decreasing
the amortised cost liability.

 

On Admission to AIM on 6 July 2022, all outstanding convertible loans
converted to equity with the Company issuing 2,716,550 Ordinary Shares to the
providers of all outstanding convertible loans.

 

12.  Borrowings

 

               31 December  31 December

               2022         2021

                            (Unaudited)

               £000         £000
 Current:
 Bank loans    7            7
 Non-current:
 Bank loans    19           26
               26           33

 

A maturity analysis of the Group's borrowings is shown below:

 

                                          31 December  31 December

                                          2022         2021

                                                       (Unaudited)

                                          £000         £000
 Less than 1 year                         7            7
 Later than 1 year and less than 5 years  19           26
 After 5 years                            -            -

 

Banks loans comprise a Coronavirus Bounce Back Loan Scheme loan provided by
HSBC.  The loan was taken out in May 2020 and matures five years after this
date.  The loan incurs interest of 2.5%.

13.  Share capital and share premium account

 

 Share capital                       31 December 2022  31 December 2021

                                                       (Unaudited)

                                     £000              £000
 Allotted, called up and fully paid
 Ordinary shares of £0.01 each       221               3
                                     221               3

 

 Share capital                       31 December  31 December

                                     2022         2021

                                                  (Unaudited)

                                     £000         £000
 Allotted, called up and fully paid
 Opening share capital               3            2
 Shares issued for cash              40           -
 Bonus issue of shares               151          -
 Convertible loan notes exercised    27           -
 Shares issued in lieu of expenses   -            1
 Closing share capital               221          3

 

 Share premium account              31 December  31 December

                                    2022         2021

                                                 (Unaudited)

                                    £000         £000
 Share premium account
 Opening balance                    4,627        3,347
 Shares issued for cash             3,047        436
 Share issue costs                  (368)        -
 Cancellation of share premium      (4,464)      -
 Issue of warrants                  (113)        -
 Convertible loan notes exercised   1,423        188
 Shares issued in lieu of expenses  -            656
 Closing balance                    4,152        4,627

 

Called up share capital

Called up share capital represents the nominal value of shares that have been
issued.  All classes of shares have full voting, dividends, and capital
distribution rights.

 

On 14 January 2022, the Company issued 2,561 new ordinary shares for cash,
increasing the number of shares in issue to 307,830.

 

On 9 May 2022, a bonus issue of shares was made for the shareholders of all
307,830 shares already in issue at the date.  The bonus issue offered 49
ordinary shares for every 1 ordinary share in issue, with a nominal value of
£0.01 per share.  This increased the number of ordinary shares in issue by
15,083,670 to 15,391,500.

 

On 6 July 2022, the Company issued 4,000,000 new ordinary shares and 2,716,550
ordinary shares to the providers of convertible loans, increasing the number
of ordinary shares in issue to 22,108,050.

14.  Post balance sheet events

 

On 21 March 2023, the Group entered into a non-revolving, £250,000 invoice
finance facility to more easily manage the working capital requirements of
sales growth, should this be required.  The facility, which is utilisable
over an initial term of six months, does not bear interest but attracts a fee
of £18,750 payable equally over the initial term.  Each drawdown is
repayable over the six months following drawdown, with the first instalment
paid at the time of the first drawdown.  The facility is not currently being
utilised.

 

15.  Full financial statements

 

The auditors have issued an unqualified opinion on the full financial
statements for the year ended 31 December 2022 which will be made available
for shareholders and delivered to the Registrar of Companies in due course.
Further copies of these results, and the full financial statements when
published, will be available on the LifeSafe Holdings plc investor relations
website, www.lifesafeholdingsplc.com (http://www.lifesafeholdingsplc.com) .

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR IRMPTMTMBBFJ

Recent news on LifeSafe Holdings

See all news